No headlines found.
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
Business Wire (Mon, 23-Dec 7:30 PM ET)
Distribution Dates and Amounts Announced for Certain BlackRock Closed-End Funds
Business Wire (Fri, 6-Dec 4:56 PM ET)
Certain BlackRock Funds Announce Expiration and Preliminary Results of Tender Offers
Business Wire (Mon, 18-Nov 9:32 PM ET)
Certain BlackRock Funds Announce Final Results of Tender Offers
Business Wire (Mon, 18-Nov 9:17 PM ET)
BlackRock Capital Allocation Trust is a non-diversified, closed-end management investment company. The investment objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation.
Blackrock Capital Allocation Term Trust Common Shares Of Beneficial Interest trades on the NYSE stock market under the symbol BCAT.
As of December 27, 2024, BCAT stock price declined to $15.34 with 598,825 million shares trading.
BCAT has a beta of 0.55, meaning it tends to be less sensitive to market movements. BCAT has a correlation of 0.23 to the broad based SPY ETF.
BCAT has a market cap of $1.65 billion. This is considered a Small Cap stock.
In the last 3 years, BCAT traded as high as $19.62 and as low as $13.32.
BCAT has underperformed the market in the last year with a price return of +20.2% while the SPY ETF gained +26.4%. BCAT has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -1.1% and -2.5%, respectively, while the SPY returned +4.5% and -1.2%, respectively.
BCAT support price is $15.35 and resistance is $15.73 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BCAT shares will trade within this expected range on the day.